Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

FDA delays Capricor's deramiocel PDUFA date to review new data

The FDA is pushing back its decision on Capricor Therapeutics’ problematic Duchenne muscular dystrophy therapy to review additional data for a more niche indication. The company on Monday said the agency has extended the PDUFA ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at endpoints.news →

More in Health & Medicine

His Hiccups Signaled a Life-Threatening Problem

(MedPage Today) -- A middle-aged man's persistent hiccups were a sign of a much more severe problem, clinicians wrote in a case report. The 55-year-old man first went to a local clinic seeking help for hiccups that lasted more than 2 weeks, as...

What is Salmonella and what can you do to avoid catching it?

Salmonella is the group of bacteria behind one of the most common types of food poisoning in the UK, and while for most people it means a few unpleasant days at home, for others it can lead to serious illness. With UKHSA currently helping to investigate a national outbreak linked to eggs, we've answered some …

More from Monday 24 August →